封面
市场调查报告书
商品编码
1619460

2024 年生物工程皮肤替代品全球市场报告

Bioengineered Skin Substitutes Global Market Report 2024

出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

生物工程皮肤替代品的市场规模预计在未来几年将快速成长。 2028年,将以13.6%的复合年增长率成长至36.3亿美元。预测期内的预期增长可归因于新生物材料的开发、不断发展的法律规范、政府倡议和资金筹措、成本效益和长期效益以及美容和重组手术的增加。这段时期的主要趋势包括法律规范、创新生物材料、基于细胞的方法、增强的血管生成技术和先进的生物製造技术的进步。

烧烫伤发病率的增加预计将推动未来生物工程皮肤替代品市场的成长。当皮肤或其他组织因热、辐射、电、摩擦或化学物质而受损时,就会发生烧伤。这类事故往往是由于安全措施不足、易燃材料使用不当以及缺乏火灾隐患和安全通讯协定意识所造成的。生物工程皮肤替代品为受损皮肤提供临时或永久的解决方案,帮助癒合,降低感染风险,并改善功能和美容效果。例如,美国烧伤协会 2023 年 11 月发布的烧伤中心住院护理分析发现,2022 年有 30,135 例烧伤病例。这导致五年内总共有 152,312 例病例,每年约有万分之一的人需要住院治疗。此类烧伤病例的增加正在推动生物工程皮肤替代品市场的成长。

生物工程皮肤替代品市场的主要企业正在推进鱼皮移植物的开发,以提高皮肤替代品的有效性和多功能性。鱼皮移植物是由鱼皮製成的创伤治疗材料,可支持组织再生和修復。例如,2024 年 2 月,冰岛伤口护理公司 Kerecis 推出了 Shield Standard,这是一种仿生皮肤替代品,由完整的鱼皮製成,内衬硅胶。该产品使用鱼皮作为天然的癒合支架,并经过最低限度的加工以保留其有益成分。它与人体皮肤具有亲和性,保留自然水分,并降低感染风险,使其适合治疗各种伤口,包括慢性和急性损伤。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球生物工程皮肤替代品市场:驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球生物工程皮肤替代品市场表现:规模和成长,2018-2023
  • 全球生物工程皮肤替代品市场预测:规模和成长,2023-2028 年、2033 年

第六章 市场细分

  • 全球生物工程皮肤替代品市场:按产品、性能和预测,2018-2023、2023-2028、2033
  • 无细胞的
  • 同种异体的
  • 不同物种
  • 自体移植
  • 其他的
  • 全球生物工程皮肤替代品市场:按应用、性能和预测,2018-2023、2023-2028、2033
  • 急性伤口
  • 慢性伤口
  • 全球生物工程皮肤替代品市场:按最终用户、绩效和预测,2018-2023、2023-2028、2033
  • 创伤护理中心
  • 医院
  • 专科诊所
  • 其他的

第 7 章 区域/国家分析

  • 全球生物工程皮肤替代品市场:按地区、绩效和预测,2018-2023、2023-2028、2033
  • 全球生物工程皮肤替代品市场:按国家、绩效和预测,2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 生物工程皮肤替代品市场:竞争格局
  • 生物工程皮肤替代品市场:公司简介
    • Stryker Corporation
    • DePuy Synthes
    • Smith & Nephew Plc
    • ConvaTec Group PLC
    • Mallinckrodt Pharmaceuticals plc

第31章 其他大型创新企业

  • Integra LifeSciences Holdings Corporation
  • Gunze Limited
  • Organogenesis Inc.
  • LifeNet Health Inc.
  • MiMedx Group Inc.
  • Vericel Corporation
  • AlloSource Inc.
  • Sientra Inc.
  • PolyNovo Limited
  • Avita Medical Limited
  • Tissue Regenix Group
  • Amarantus Bioscience Holdings Inc.
  • PolarityTE
  • Promethean LifeSciences Inc.
  • Regenicin Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r20491

Bioengineered skin substitutes are artificial or lab-grown materials designed to mimic the function and structure of human skin. They are created using biological, synthetic, or a combination of materials and are primarily used to treat severe skin injuries or conditions that require skin replacement or regeneration, such as burns, chronic wounds, ulcers, or reconstructive surgeries.

The main types of bioengineered skin substitutes include acellular, allogeneic, xenogeneic, autologous, and others. Acellular skin substitutes are made from skin tissues with all cells removed, leaving only the structural framework. These substitutes are used for various applications, including acute and chronic wounds, and are utilized by different end users such as wound care centers, hospitals, specialty clinics, and others.

The bioengineered skin substitutes market research report is one of a series of new reports from The Business Research Company that provides bioengineered skin substitutes market statistics, including bioengineered skin substitutes industry global market size, regional shares, competitors with a bioengineered skin substitutes market share, detailed bioengineered skin substitutes market segments, market trends and opportunities, and any further data you may need to thrive in the bioengineered skin substitutes industry. This bioengineered skin substitutes market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bioengineered skin substitute market size has grown rapidly in recent years. It will grow from $1.92 billion in 2023 to $2.18 billion in 2024 at a compound annual growth rate (CAGR) of 13.4%. The growth during the historic period can be attributed to rising investment in research and development, improvements in healthcare infrastructure, an increase in reconstructive and cosmetic surgeries, higher healthcare spending, and better patient outcomes.

The bioengineered skin substitute market size is expected to see rapid growth in the next few years. It will grow to $3.63 billion in 2028 at a compound annual growth rate (CAGR) of 13.6%. The anticipated growth in the forecast period can be attributed to the development of new biomaterials, evolving regulatory frameworks, government initiatives and funding, cost-effectiveness and long-term benefits, and a rise in aesthetic and reconstructive surgeries. Key trends during this period include advancements in regulatory frameworks, innovative biomaterials, cell-based approaches, enhanced vascularization techniques, and advanced biofabrication methods.

The increasing incidence of burn cases is expected to drive the growth of the bioengineered skin substitute market in the future. Burn cases involve injuries from damage to the skin or other tissues caused by heat, radiation, electricity, friction, or chemicals. These incidents often result from inadequate safety measures, improper use of flammable materials, and insufficient awareness of fire hazards and safety protocols. Bioengineered skin substitutes offer temporary or permanent solutions for damaged skin, aiding in healing, reducing infection risk, and enhancing both functional and cosmetic outcomes. For example, an analysis of inpatient care at burn centers published by the American Burn Association in November 2023 reported 30,135 burn cases in the U.S. in 2022. This contributed to a five-year total of 152,312 cases, with about 1 in 10,000 people needing inpatient care annually. This increasing number of burn cases is fueling the growth of the bioengineered skin substitute market.

Leading companies in the bioengineered skin substitute market are advancing the development of fish skin grafts to improve the effectiveness and versatility of skin substitutes. Fish-skin grafts are wound-healing materials made from processed fish skin, which support tissue regeneration and repair. For instance, in February 2024, Kerecis, a wound care company based in Iceland, launched Shield Standard, a bioengineered skin substitute featuring intact fish skin with a silicone backing. This product uses fish skin as a natural scaffold for healing, with minimal processing to preserve its beneficial components. It provides biocompatibility with human skin, retains natural moisture, and reduces infection risk, making it suitable for treating various wounds, including chronic and acute injuries.

In August 2023, Coloplast A/S, a healthcare company based in Denmark, acquired Kerecis for $1.3 billion. This acquisition is aimed at enhancing Coloplast's position in the advanced wound care market, especially within the US-centric biologics segment. Kerecis, an Iceland-based manufacturer, specializes in bioengineered skin substitutes derived from fish skin.

Major companies operating in the bioengineered skin substitutes market are Stryker Corporation, DePuy Synthes, Smith & Nephew Plc, ConvaTec Group PLC, Mallinckrodt Pharmaceuticals plc, Integra LifeSciences Holdings Corporation, Gunze Limited, Organogenesis Inc., LifeNet Health Inc., MiMedx Group Inc., Vericel Corporation, AlloSource Inc., Sientra Inc., PolyNovo Limited, Avita Medical Limited, Tissue Regenix Group, Amarantus Bioscience Holdings Inc., PolarityTE, Promethean LifeSciences Inc., Regenicin Inc.

North America was the largest region in the bioengineered skin substitutes market in 2023. The regions covered in the bioengineered skin substitutes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioengineered skin substitutes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioengineered skin substitutes market consists of sales of products including apligraf, dermagraft, epicel, transcyte, and orcel. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioengineered Skin Substitutes Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioengineered skin substitutes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioengineered skin substitutes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioengineered skin substitutes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Acellular; Allogeneic; Xenogeneic; Autologous; Other Products
  • 2) By Application: Acute Wounds; Chronic Wounds
  • 3) By End User: Wound Care Centers; Hospitals; Specialty Clinics; Other End Users
  • Companies Mentioned: Stryker Corporation; DePuy Synthes; Smith & Nephew Plc; ConvaTec Group PLC; Mallinckrodt Pharmaceuticals plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioengineered Skin Substitutes Market Characteristics

3. Bioengineered Skin Substitutes Market Trends And Strategies

4. Bioengineered Skin Substitutes Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Bioengineered Skin Substitutes Market Size and Growth

  • 5.1. Global Bioengineered Skin Substitutes Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Bioengineered Skin Substitutes Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Bioengineered Skin Substitutes Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Bioengineered Skin Substitutes Market Segmentation

  • 6.1. Global Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Acellular
  • Allogeneic
  • Xenogeneic
  • Autologous
  • Other Products
  • 6.2. Global Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Acute Wounds
  • Chronic Wounds
  • 6.3. Global Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Wound Care Centers
  • Hospitals
  • Specialty Clinics
  • Other End Users

7. Bioengineered Skin Substitutes Market Regional And Country Analysis

  • 7.1. Global Bioengineered Skin Substitutes Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Bioengineered Skin Substitutes Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Bioengineered Skin Substitutes Market

  • 8.1. Asia-Pacific Bioengineered Skin Substitutes Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Bioengineered Skin Substitutes Market

  • 9.1. China Bioengineered Skin Substitutes Market Overview
  • 9.2. China Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Bioengineered Skin Substitutes Market

  • 10.1. India Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Bioengineered Skin Substitutes Market

  • 11.1. Japan Bioengineered Skin Substitutes Market Overview
  • 11.2. Japan Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Bioengineered Skin Substitutes Market

  • 12.1. Australia Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Bioengineered Skin Substitutes Market

  • 13.1. Indonesia Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Bioengineered Skin Substitutes Market

  • 14.1. South Korea Bioengineered Skin Substitutes Market Overview
  • 14.2. South Korea Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Bioengineered Skin Substitutes Market

  • 15.1. Western Europe Bioengineered Skin Substitutes Market Overview
  • 15.2. Western Europe Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Bioengineered Skin Substitutes Market

  • 16.1. UK Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Bioengineered Skin Substitutes Market

  • 17.1. Germany Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Bioengineered Skin Substitutes Market

  • 18.1. France Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Bioengineered Skin Substitutes Market

  • 19.1. Italy Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Bioengineered Skin Substitutes Market

  • 20.1. Spain Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Bioengineered Skin Substitutes Market

  • 21.1. Eastern Europe Bioengineered Skin Substitutes Market Overview
  • 21.2. Eastern Europe Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Bioengineered Skin Substitutes Market

  • 22.1. Russia Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Bioengineered Skin Substitutes Market

  • 23.1. North America Bioengineered Skin Substitutes Market Overview
  • 23.2. North America Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Bioengineered Skin Substitutes Market

  • 24.1. USA Bioengineered Skin Substitutes Market Overview
  • 24.2. USA Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Bioengineered Skin Substitutes Market

  • 25.1. Canada Bioengineered Skin Substitutes Market Overview
  • 25.2. Canada Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Bioengineered Skin Substitutes Market

  • 26.1. South America Bioengineered Skin Substitutes Market Overview
  • 26.2. South America Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Bioengineered Skin Substitutes Market

  • 27.1. Brazil Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Bioengineered Skin Substitutes Market

  • 28.1. Middle East Bioengineered Skin Substitutes Market Overview
  • 28.2. Middle East Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Bioengineered Skin Substitutes Market

  • 29.1. Africa Bioengineered Skin Substitutes Market Overview
  • 29.2. Africa Bioengineered Skin Substitutes Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Bioengineered Skin Substitutes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Bioengineered Skin Substitutes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Bioengineered Skin Substitutes Market Competitive Landscape And Company Profiles

  • 30.1. Bioengineered Skin Substitutes Market Competitive Landscape
  • 30.2. Bioengineered Skin Substitutes Market Company Profiles
    • 30.2.1. Stryker Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. DePuy Synthes
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Smith & Nephew Plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. ConvaTec Group PLC
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Mallinckrodt Pharmaceuticals plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Bioengineered Skin Substitutes Market Other Major And Innovative Companies

  • 31.1. Integra LifeSciences Holdings Corporation
  • 31.2. Gunze Limited
  • 31.3. Organogenesis Inc.
  • 31.4. LifeNet Health Inc.
  • 31.5. MiMedx Group Inc.
  • 31.6. Vericel Corporation
  • 31.7. AlloSource Inc.
  • 31.8. Sientra Inc.
  • 31.9. PolyNovo Limited
  • 31.10. Avita Medical Limited
  • 31.11. Tissue Regenix Group
  • 31.12. Amarantus Bioscience Holdings Inc.
  • 31.13. PolarityTE
  • 31.14. Promethean LifeSciences Inc.
  • 31.15. Regenicin Inc.

32. Global Bioengineered Skin Substitutes Market Competitive Benchmarking

33. Global Bioengineered Skin Substitutes Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Bioengineered Skin Substitutes Market

35. Bioengineered Skin Substitutes Market Future Outlook and Potential Analysis

  • 35.1 Bioengineered Skin Substitutes Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Bioengineered Skin Substitutes Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Bioengineered Skin Substitutes Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer